Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism

Experimental Neurology

Volumn 210, Issue 1, 2008, Pages 257-260

  Harnack, Daniel ^a   Meissner, Wassilios ^b   Jira, Julia A ^a   Winter, Christine ^a   Morgenstern, Rudolf ^a   Kupsch, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HAUT LÉVÊQUE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; DISEASE COURSE; DOPAMINERGIC NERVE CELL; ELECTRODE; MALE; NERVE DEGENERATION; NEUROPROTECTION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTRIC STIMULATION; MALE; NEURONS; PARKINSON DISEASE; RATS; RATS, WISTAR; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS;

EID: 39149124879     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2007.10.002     Document Type: Article

References (17)

1. Bergman H., Wichmann T., Karmon B., and DeLong M.R. The primate subthalamic nucleus: II. Neuronal activity in the MPTP model of parkinsonism. J. Neurophysiol. 72 (1994) 507-520
2. Carvalho G.A., and Nikkhah G. Subthalamic nucleus lesions are neuroprotective against terminal 6-OHDA-induced striatal lesions and restore postural balancing reactions. Exp. Neurol. 171 (2001) 405-417
3. Harnack, D., Meissner, W., Paulat, R., Hilgenfeld, H., Müller, W.D., Winter, C., Morgenstern, R., Kupsch, A., in press. Continuous high frequency stimulation in freely moving rats:development of an implantable microstimulation system. J. Neurosci. Methods. doi:10.1016/j.jneumeth.2007.08.019.
4. Harnack D., Winter C., Meissner W., Reum T., Kupsch A., and Morgenstern R. The effects of electrode material, charge density and stimulation duration on the safety of high-frequency stimulation of the subthalamic nucleus in rats. J. Neurosci. Methods 138 (2004) 207-216
5. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., Koudsie A., Limousin P.D., Benazzouz A., LeBas J.F., Benabid A.L., and Pollak P. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 349 (2003) 1925-1934
6. Maesawa S., Kaneoke Y., Kajita Y., Usui N., Misawa N., Nakayama A., and Yoshida J. Long-term stimulation of the subthalamic nucleus in hemiparkinsonian rats: neuroprotection of dopaminergic neurons. J. Neurosurg. 100 (2004) 679-687
7. Meissner W., Dovero S., Bioulac B., Gross C.E., and Bezard E. Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiol. Dis. 13 (2003) 46-54
8. Meissner W., Leblois A., Hansel D., Bioulac B., Gross C.E., Benazzouz A., and Boraud T. Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain 128 (2005) 2372-2382
9. Oiwa Y., Sanchez-Pernaute R., Harvey-White J., and Bankiewicz K.S. Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease. J. Neurosurg. 98 (2003) 136-144
10. Paul G., Meissner W., Rein S., Harnack D., Winter C., Hosmann K., Morgenstern R., and Kupsch A. Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease. Exp. Neurol. 185 (2004) 272-280
11. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 2nd ed. (1986), Academic Press, San Diego
12. Piallat B., Benazzouz A., and Benabid A.L. Subthalamic nucleus lesion in rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: behavioural and immunohistochemical studies. Eur. J. Neurosci. 8 (1996) 1408-1414
13. Rodriguez M.C., Obeso J.A., and Olanow C.W. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann. Neurol. 44 (1998) S175-S188
14. Tai C.H., Boraud T., Bezard E., Bioulac B., Gross C., and Benazzouz A. Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J. 17 (2003) 1820-1830
15. Temel Y., Visser-Vandewalle V., Kaplan S., Kozan R., Daemen M.A., Blokland A., Schmitz C., and Steinbusch H.W. Protection of nigral cell death by bilateral subthalamic nucleus stimulation. Brain Res. 1120 (2006) 100-105
16. Theoret H., Boire D., Herbin M., and Ptito M. Stereological evaluation of substantia nigra cell number in normal and hemispherectomized monkeys. Brain Res. 835 (1999) 354-359
17. Wallace B.A., Ashkan K., Heise C.E., Foote K.D., Torres N., Mitrofanis J., and Benabid A.L. Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 130 (2007) 2129-2145